Pharmabiz

Xenix Medical’s Riva Anchor Spinopelvic fixation system receives US FDA 510(k) clearance with NanoACTIV surface technology

Xenix Medical’s Riva Anchor Spinopelvic fixation system receives US FDA 510(k) clearance with NanoACTIV surface technology: Orlando, Florida Friday, September 25, 2026, 13:00 Hr ...
Pharmabiz

Parexel Transforms FSP Model to improve R&D productivity, post-approval product lifecycle services for biopharma cos

Parexel Transforms FSP Model to improve R&D productivity, post-approval product lifecycle services for biopharma cos: Our Bureau, Bengaluru Friday, September 25, 2026, 12:30 Hrs [ ...
Pharmabiz

NCLT approves merger of Sesa Care with Dabur India

Dabur India Limited announced that the National Company Law Tribunal (NCLT), New Delhi Bench, in its hearing held on September 24, 2026, has sanctioned the Scheme of Amalgamation of Sesa Care Private ...
Pharmabiz

NIH funded study shows modified HIV drug reverses vision loss and paralysis in multiple sclerosis model

NIH funded study shows modified HIV drug reverses vision loss and paralysis in multiple sclerosis model: Bethesda, Maryland Friday, September 25, 2026, 12:00 Hrs [IST] A new Natio ...
Pharmabiz

Alexion advances pioneering leadership in gMG care with data at 2026 AANEM Annual Meeting and MGFA Scientific Session

Alexion advances pioneering leadership in gMG care with data at 2026 AANEM Annual Meeting and MGFA Scientific Session: Cambridge, UK Friday, September 25, 2026, 11:00 Hrs [IST] Al ...
Pharmabiz

UK MHRA grants marketing approval to Pharma Mar’s lurbinectedin for adults with extensive-stage small cell lung cancer

UK MHRA grants marketing approval to Pharma Mar’s lurbinectedin for adults with extensive-stage small cell lung cancer: United Kingdom Friday, September 25, 2026, 10:00 Hrs [IST ...
Pharmabiz

Merck’s remigromig meets primary endpoint in the pivotal phase 2b/3 BRUNELLO study of adults with diabetic macular edema

Merck’s remigromig meets primary endpoint in the pivotal phase 2b/3 BRUNELLO study of adults with diabetic macular edema: Rahway, New Jersey Friday, September 25, 2026, 09:00 Hr ...
Pharmabiz

DTAB asks DCC to deliberate on inclusion of all sterile drug products under the purview of CLAA

DTAB asks DCC to deliberate on inclusion of all sterile drug products under the purview of CLAA: Our Bureau, New Delhi Friday, September 25, 2026, 08:00 Hrs [IST] The Drugs Techni ...
Pharmabiz

Commerce ministry to expand market access for Indian pharma exporters in Africa

Commerce ministry to expand market access for Indian pharma exporters in Africa: Shardul Nautiyal, Mumbai Friday, September 25, 2026, 08:00 Hrs [IST] In order to expand market acc ...
Pharmabiz

DTAB recommends prohibition of topical medicine lindane

The Drugs Technical Advisory Board (DTAB) has revised its recommendation regarding the manufacturing, sale and import of lindane, a topical medicine used against scabies and lice infestations, ...
Pharmabiz

US FDA, Gujarat FDCA continue strengthening regulatory collaboration on drug quality and compliance

US FDA, Gujarat FDCA continue strengthening regulatory collaboration on drug quality and compliance: Shardul Nautiyal, Mumbai Friday, September 25, 2026, 08:00 Hrs [IST] The US Fo ...
Pharmabiz

AstraZeneca expands company’s $100 million+ commitment to advance youth health equity in more than 60 countries

AstraZeneca expands company’s $100 million+ commitment to advance youth health equity in more than 60 countries: Cambridge, UK Thursday, September 24, 2026, 16:00 Hrs [IST] Astr ...